Mumbai, Sep 9 : Pharma Major, Dr Reddy’s Labs announced the launch of over-the-counter (OTC) Diclofenac Sodium Topical Gel 1 per cent, the store brand version of Voltaren Arthritis Pain in the US market.
“The launch of Dr Reddy’s Diclofenac Sodium Topical Gel, 1 pc OTC, is an important addition to our Pain / Analgesics portfolio of OTC products, and represents our continued commitment to the Private Label OTC space,” says Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories. “We are pleased to partner with Encube Ethicals to bring this product to market for the benefit of consumers.”
Dr Reddy’s Diclofenac Sodium Topical Gel, 1% (OTC), is used for the temporary relief of arthritis pain ONLY in the, hand, wrist, elbow (upper body areas) and – foot, ankle, knee (lower body areas)
Voltaren Arthritis Pain brand had total U.S. retail sales of approximately $44 million since launch in May 2020 according to IRI*.
Dr Reddy’s Diclofenac Sodium Topical Gel, 1 pc (OTC), will soon be available in multiple pack sizes to allow consumers a variety of purchasing options.